MedImmune says that a late-stage trial of a refrigerator-stable version of its FluMist flu vaccine was successful in demonstrating its effectiveness. The Gaithersburg, Maryland, biotech has been sorely disappointed in FluMist sales to date. Story [1]
Links:
[1] http://washington.bizjournals.com/washington/stories/2005/06/13/daily32.html